PT1948216E - Variante da trombomodulina - Google Patents

Variante da trombomodulina Download PDF

Info

Publication number
PT1948216E
PT1948216E PT06825898T PT06825898T PT1948216E PT 1948216 E PT1948216 E PT 1948216E PT 06825898 T PT06825898 T PT 06825898T PT 06825898 T PT06825898 T PT 06825898T PT 1948216 E PT1948216 E PT 1948216E
Authority
PT
Portugal
Prior art keywords
soluble thrombomodulin
renal failure
acute renal
treatment
thrombomodulin
Prior art date
Application number
PT06825898T
Other languages
English (en)
Portuguese (pt)
Inventor
Brian William Grinnell
Thurman Dwight Mckinney
Bruce A Molitoris
Original Assignee
Lilly Co Eli
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Indiana Res & Tech Corp filed Critical Lilly Co Eli
Publication of PT1948216E publication Critical patent/PT1948216E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT06825898T 2005-10-13 2006-10-12 Variante da trombomodulina PT1948216E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72637605P 2005-10-13 2005-10-13

Publications (1)

Publication Number Publication Date
PT1948216E true PT1948216E (pt) 2011-05-06

Family

ID=37670944

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06825898T PT1948216E (pt) 2005-10-13 2006-10-12 Variante da trombomodulina

Country Status (13)

Country Link
US (1) US20080255047A1 (cg-RX-API-DMAC7.html)
EP (1) EP1948216B1 (cg-RX-API-DMAC7.html)
JP (1) JP5405829B2 (cg-RX-API-DMAC7.html)
AT (1) ATE503489T1 (cg-RX-API-DMAC7.html)
CA (1) CA2625888C (cg-RX-API-DMAC7.html)
CY (1) CY1112438T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006021048D1 (cg-RX-API-DMAC7.html)
DK (1) DK1948216T3 (cg-RX-API-DMAC7.html)
ES (1) ES2360610T3 (cg-RX-API-DMAC7.html)
PL (1) PL1948216T3 (cg-RX-API-DMAC7.html)
PT (1) PT1948216E (cg-RX-API-DMAC7.html)
SI (1) SI1948216T1 (cg-RX-API-DMAC7.html)
WO (1) WO2007047430A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073884A2 (en) * 2006-12-12 2008-06-19 Eli Lilly And Company Treating acute renal failure with soluble thrombomodulin variants
WO2010056472A2 (en) * 2008-11-12 2010-05-20 Eli Lilly And Company Compositions and methods of use for thrombomodulin variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
DE69333491T2 (de) * 1992-02-05 2005-03-31 Paion Gmbh Protease-Resistant Thrombomodulin Analogs
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
CA2515916A1 (en) * 2003-02-25 2004-09-10 Biovec B.V. Therapeutic applications of thrombomodulin gene via viral and non-viral vectors

Also Published As

Publication number Publication date
CA2625888A1 (en) 2007-04-26
CA2625888C (en) 2015-09-22
PL1948216T3 (pl) 2011-10-31
ES2360610T3 (es) 2011-06-07
WO2007047430A8 (en) 2008-04-10
EP1948216B1 (en) 2011-03-30
WO2007047430A3 (en) 2007-05-24
JP2009511597A (ja) 2009-03-19
JP5405829B2 (ja) 2014-02-05
EP1948216A2 (en) 2008-07-30
CY1112438T1 (el) 2015-12-09
SI1948216T1 (sl) 2011-07-29
US20080255047A1 (en) 2008-10-16
DE602006021048D1 (de) 2011-05-12
WO2007047430A2 (en) 2007-04-26
ATE503489T1 (de) 2011-04-15
DK1948216T3 (da) 2011-06-06

Similar Documents

Publication Publication Date Title
IL160420A0 (en) Treating or preventing diabetes with cannabidiol
MX353727B (es) Tratamiento de sinucleinopatias.
MX391921B (es) Nepicastat para usarse en el tratamiento de dependencia
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
EA201001771A1 (ru) Лечение релаксином одышки, ассоциированной с острой сердечной недостаточностью
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
WO2009044173A3 (en) Methods of treating cancer using notch pathway inhibitors
WO2007081879A3 (en) Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
DK1809661T3 (da) Humant interferon-beta-mutein
WO2007038768A3 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
EP2754447A3 (en) Treating acute renal failure with soluble thrombomodulin variants
IL190496A0 (en) Methods for reducing blood pressure
EP2716285A3 (en) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
CY1112438T1 (el) Μεθοδος αγωγης της οξειας νεφρικης ανεπαρκειας με διαλυτη θρομβομοδουλινη
MX2010006443A (es) TRATAMIENTO DE CARDIOPATIAS USANDO ß-BLOQUEANTES.
SG196770A1 (en) Method for treating macular degeneration
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
MY140538A (en) Substituted n-acyl-2-aminothiazoles
TN2011000206A1 (en) Compositions and methods of use soluble thrombomodulin variants
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
WO2007017652A3 (en) Arylakylamines for the treatment of cancer
ATE454144T1 (de) Behandlung von malignen neoplasien
WO2007058957A3 (en) Boroproline compound and cytokine combination therapy
TW200640484A (en) Treatment of brain tissue damage